AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Diagnostic Performance of Breast Cancer Screening Second Reading Process Assisted by AI

RecruitingNAAges 50 Years - 74 YearsFemaleTherapixel
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to compare, for the second reading of screening mammograms, the standard of care with an AI assisted scenario. The main questions it aims to answer are: * will the experimental pathway be non-inferior to the standard pathway? * will the experimental pathway be economically superior to the standard pathway? Participants will receive screening mammograms, as part of the breast cancer screening program. Researchers will compare the interpretation made by the second reader in the standard pathway with the AI assisted interpretation made by a different reader in the experimental pathway.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Affiliated to the French social security system * Whose mammograms meet the following characteristics: 4 (2 per breast, CC and MLO) meeting local regulatory standards and with correct DICOM metadata, * Whose mammograms have been determined to be normal or to have benign lesions by the radiologist who performed the first reading of the images (L1) in the framework of the organized breast cancer screening program * Having expressed her willingness to participate in the study, to undergo all the procedures and to make herself available for the expected duration of their participation, * Having completed and signed the informed consent form. Exclusion Criteria: * Woman with breast implants, * With clinical symptoms of breast cancer, * With a history of breast surgery (breast reduction or surgery for benign lesion), * Pregnant or breastfeeding, * With medical conditions that may interfere with her ability to understand the requirements of the protocol or give informed consent, * Deprived of liberty by judicial or administrative order, * Participant whose mammogram images have at least one of the following defects: poor quality of the images, non-standard mammography (projection, magnification, compression), ML/LM/SIO/XCCL or XCCM view.
💊

What it tests

  • MammoScreen
📍

Where

7 sites
Centre de radiologie Les Défensions
Aubagne, France
Var Imagerie Medicale
Draguignan, France
VAR IMAGERIE MEDICALE - Centre d'Imagerie Médicale Le Clipper
Fréjus, France
VAR IMAGERIE MEDICALE - Clinique Les Lauriers
Fréjus, France
Cabinet de Radiologie du Cabot
Marseille, France
Centre de Sénologie Mermoz
Marseille, France
VAR IMAGERIE MEDICALE - Centre d'Imagerie Médicale Epsilon
Saint-Raphaël, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy